Suzuki–Miyaura–hydrogenation targets 3D drugs
Researchers design a new pathway to make sp3 enriched drug molecules
Scientists in the UK have unveiled a way to make pharmaceutical molecules with increased 3D characteristics. The single pot Suzuki–Miyaura–hydrogenation reaction results in sp2–sp3 linked pharmaceutically relevant molecules.